Prodrugs of piperazine and substituted piperidine antiviral agents

Details for Australian Patent Application No. 2005223736 (hide)

Owner Bristol-Myers Squibb Company

Inventors Thoraval, Dominique; Soundararajan, Nachimuthu; Pack, Shawn K.; Meanwell, Nicholas A.; Zhang, Zhongxing; Leahy, David Kenneth; Yeung, KapSun; Kadow, John F.; Levesque, Kathia; Ueda, Yasutsugu; Chen, Chung-Pin H.; Sirard, Pierre; Connolly, Timothy P.; Wang, Tao

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005223736

PCT Pub. Number WO2005/090367

Priority 60/553,320 15.03.04 US; 60/635,231 10.12.04 US

Filing date 3 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 26 May 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/437 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07F 9/09 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/572 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/090367 Priority application(s): WO2005/090367

26 May 2011 Application Accepted

  Published as AU-B-2005223736

16 June 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 May 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

6 October 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 May 2011

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223738-3-'4-heterocyclyl - 1,2,3,-triazol-1-yl-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases

2005223729-Novel amination process